Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression
Crossref DOI link: https://doi.org/10.1007/s00280-014-2610-x
Published Online: 2014-10-26
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Heyan
Takayama, Koichi
Wang, Shuo
Shiraishi, Yoshimasa
Gotanda, Keisuke
Harada, Taishi
Furuyama, Kazuto
Iwama, Eiji
Ieiri, Ichiro
Okamoto, Isamu
Nakanishi, Yoichi
License valid from 2014-10-26